Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-09-22 00:00:00 ET · period of report 2023-09-21 · accession 0001517026-23-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 2023-09-21 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $16.77 | -1,076 | 261.6K | -0.4% | -$18.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-21 | F | D | 1,076 | $16.77 | 261,628 | D | — | — |